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Risk Factors for Nosocomial Bacteremia due to 
Methicillin-Resistant Staphylococcus aureus 
M. Pujol  1.,  C. Pef ia 1, R. Pal lares 1, J. Ayats  2, J. Ar iza  1, E Gud io l  1 
In a prospective surveillance study (February 1990-December 1991) performed at a 
1000-bed teaching hospital to identify risk factors for nosocomial methicillin-resistant 
Staphylococcus aureus (MRSA) bacteremia, 309 patients were found to be colonized 
(n = 103; 33 %) or infected (n = 206; 67 %) by MRSA. Sixty-three of them developed 
bacteremia. Compared with 114 patients who had nosocomial bacteremia caused by 
methiciilin-sensitive Staphylococcus aureus during the same period of time, MRSA 
baeteremic patients had more severe underlying diseases (p < 0.01), were more often 
in intensive care units (p < 0.01) and had received prior antibiotic therapy more 
frequently (p < 0.01). To further identify risk factors for MRSA bacteremia, univariate 
and multivariate analyses of this series of 309 patients were performed using the occur- 
rence of MRSA bacteremia s the dependent variable. Among 14 variables analyzed, 
intravascular catheterization, defined as one or more intravascular catheters in place 
for more than 48 h, was the only variable selected by a logistic regression model as an 
independent risk factor (OR = 2.7, CI = 1.1-6.6). The results of this study reinforce the 
concept hat recent antibiotic therapy may predispose patients to MRSA infection and 
suggest hat among patients colonized or infected by MRSA, those with intravascular 
catheters are at high risk of developing MRSA bacteremia. 
Since 1989 (1, 2) methicillin-resistant S aphylo- 
coccus aureus (MRSA)  has been detected in the 
majority of Spanish tertiary hospitals as a micro- 
organism responsible for an increasing number of 
nosocomia] staphylococcal infections. The intro- 
duction of an epidemic strain in our hospital at 
the end of 1989 resulted in a large outbreak of in- 
fections. Between February 1990 and December  
1991, we prospectively identified all patients with 
MRSA colonization or infection, using a specific 
protocol. One of the most striking clinical obser- 
vations was that 30 % of infected patients had 
MRSA bacteremia. As we were concerned about 
the relevance of bloodstream infections in this 
population, we performed the present study to 
determine the risk factors for development of no- 
socomial MRSA bacteremia mong hospitalized 
patients with MRSA colonization or infection. 
l Infectious Disease Service, and 2Microbiology Service, 
Hospital de Bellvitge, University of Barcelona, L'Hospi- 
talet de Llobregat, 08907 Barcelona, Spain. 
Patients and Methods 
Setth~g. Hospital de Bellvitge is a 1,000-bed teaching 
hospital for adult patients in the Barcelona rea which 
provides acute medical and surgical care, excluding pe- 
diatrics, obstetrics and burns. Our hospital has five in- 
tensive care units (ICUs) with 60 beds and an active 
organ transplant program. Yearly admittance is about 
22,000 patients. 
blfection Control Policy. A bloodstream infection sur- 
veillance program has been carried out in our hospital 
since 1984. All patients with bacteremia dentified aily 
at our microbiology laboratory are visited by an infec- 
tious diseases physician who fills out a computer-assisted 
protocol and provides medical advice when indicated. 
An active MRSA infection control program was intro- 
duced in 1990 after the detection of initial isolates. The 
program involves identification and isolation of all 
patients with MRSA colonization or infection, use of 
nasal mupirocin for health care workers and patients, 
and reinforcement of careful handwashing and edu- 
cational programs throughout the hospital. Cases are 
identified by daily laboratory surveillance of positive cul- 
tures, screening of the roommate in sporadic cases, 
screening of the ward when a cluster of cases occurs, and 
detection of rehospitalized patients with previous MRSA. 
All MRSA infected or colonized patients are visited by 
one of the authors and included in a computer-assisted 
surveillance protocol. 
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Study Design. With the data collected in the above-men- 
tioned surveillance program during 1990 and 1991, we 
performed two types of analyses. First, we compared 
Consecutive patients with nosocomial bacterernia due to 
methicillin-sensitive Staphylococcus aureus (MSSA) and 
Patients with nosocomial baeteremia due to MRSA. Vari- 
ables compared in this analysis were age and sex; under- 
lying diseases; clinical status; length of hospitalization 
prior to bacteremia; prior surgery; prior antibiotic ther- 
apy; prior intensive care setting; devices in place such as 
endotracheal intubation, intravaseular catheterization 
~ nd urinary catheter; sources of infection; and outcome. 
t econdly, we carried out univariate and multivariate ana- 
yses of all cases of MRSA colonization or infection, 
Using the occurrence of baeteremia s the dependent 
variable. Variables analyzed before the development of
bacteremia were demographic characteristics, underlying 
diseases, clinical status, length of hospital stay prior to 
the first MRSA culture, prior surgery, prior antibiotic 
therapy, prior intensive care setting, intravascutar cathe- 
terization, administration of total parenteral nutrition, 
Urinary catheterization, tracheostomy, decubitus ulcers 
and source of infection. 
Colonization and Infection. Patients with MRSA-positive 
cultures at any body site but without related signs or 
~ mptoms of infection were considered to be colonized. 
enters for Disease Control (CDC) standard efinitions 
for nosocomial infections (3) were used for suspected 
MRSA infections. Patients were considered to have 
Staphylococcal bacteremia when one or more blood cul- 
tures were positive for Staphylococcus aureus in a clinical 
ct~urse of infection. Bacteremia was considered nosocom- 
ially acquired if it appeared 72 h after admission and no 
evidence of staphylococcal infection had been present at 
admission. 
Source of Infection. Primary baeteremia was defined ac- 
COrding to CDC criteria (3) as those episodes of 
baeteremia of unknown source and those due to in- 
travascular catheter infection. An intravascular catheter 
Was considered to be the source of infection when no 
Other focus of infection was found and when one or more 
of the following conditions were confirmed: semiquanti- 
tative, tip culture using the technique of Maki et al. (4) 
Indicating ~ 15 cfu of Staphylococcus aureus, inflamma- 
Uon at the site of insertion, or clear resolution of febrile 
Yndrome after catheter removal. Othcr localized loci of 
acteremia such as respiratory tract infection r surgical 
Wound infection, for example, were considered to be 
Secondary foci of bacteremia. 
EXposure to Risk Factors. Undtrlying diseases were 
classified into three groups according to the classification 
~ MeCabe and Jackson (5): Group 1, chronic or curable 
alSease; Group 2: malignancy or any other disease with 
d. life expectancy of less than five years; and Group 3, 
plSeases with a life expectancy of less than one year. 
revious antibiotic therapy was defined as that adminis- 
tered for more than 48 h during the ten days prior to the 
Patient's first positive culture for MRSA. Intravascular 
Catheterization was defined as the presence of one or 
w~,or.e intravascular catheters for more than 48 h in the 
de~ k prior to the first positive MRSA culture. Other 
w~oV lees such as urinary catheter and endotracheal tube 
ere  considered risk factors if they were in place for 
~t l l3 re  l • - . " .  . 
han 48 h durmg the ten days prior to the tsolatlon 
of MRSA. Clinical status was measured by Apache II 
score .  
Outcome. Death was considered attributable to staphy- 
lococcal bacteremia when one or more of the following 
conditions were present: blood culture positive for 
Staphylococcus aureus at the time of death, persistent 
signs or symptoms of staphylococcal infection at death, 
or death within the first week of staphylococcal 
bacteremia without other clear explanation. 
Microbiological Methods. Screening swabs collected from 
the anterior nares of infected or colonized patients and 
all other clinical specimens submitted to the laboratory 
for MRSA screening were inoculated onto mannitol-salt 
agar plates. All cultures were incubated at 35 *C for two 
days and examined aily for evidence of growth. 
Blood cultures were performed by inoculating 5-10 ml 
of blood into a commercial two-bottle system (Baetee 
system; Becton Dickinson Diagnostic Instrument Sys- 
tems, USA). Gram-positive, catalase-positive cocci were 
identified as Staphylococcus aureus in accordance with 
their growth characteristics on mannitol-salt agar, DNA 
hydrolysis, latex agglutination (Slidex StaphKit; bio- 
M6rieux, France) and the oagulase r action. One isolate 
of Staphylococcus aureus per patient was stored frozen 
at -20 *C in skim milk. 
Susceptibility to oxacillin was tested by disk diffusion 
and microbroth dilution methods. For the disk diffusion 
test, a 1 ~tg oxacillin disk and standard zone size criteria 
were used (6). Other antibiotics tested by disk diffusion 
methods were gentamicin, erythromycin, tetracycline, 
clindamycin, rifampin, ciprofloxaein, chloramphenicol, 
trimethoprim/sulfamethoxazole, vancomycin, fosfomy- 
cin, mupirocin and fusidic acid. The minimum inhibitory 
concentration (M/C) was determined by commercial 
plates (Pos Combo Panel 4I; MicroScan, USA), with two 
oxacillin dilution wells of 1 lag/ml and 2 ~ag/ml, supple- 
mented with 2 % NaCI. The microdilution trays were 
inoculated with an inoculum of 10 s cfu/ml and incubated 
at 35 *C for 24 h. Using NCCLS criteria, the organism 
was considered resistant o oxacillin if the MIC was 
greater than 2 ~g/ml. 
Bacteriophage typing was performed by the Reference 
Laboratory (Ccntro Nacional de Microbiologfa de Ma- 
jadahonda Madrid) using standard methods (7) with the 
international test of phages and standard routine test 
dilution. Plasmid pattern profiles in the first 40 isolates 
were determined by agarose gel clectrophorcsis (8). 
Statistical Analysis. Rates of monthly staphylococcal 
bacteremia were compared using the Chi-square test for 
trends. Risk factors among patients with nosocomial 
MRSA bacteremia nd among those with nosocomial 
MSSA bacteremia were compared using the Chi-square, 
Fisher's exact, or Student's t-test when appropriate. Uni- 
variate analyses were also done to determine the signif- 
icance of risk factors for development of nosocomial 
bacteremia among patients with MRSA colonization or 
infection. Unconditional logistic regression analysis was 
used to assess the independence of variables found statis- 
tically significant in the univariate analysis. Statistical 
analyses were executed by using the SPSS/PC microcom- 
puter statistical package. 
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Results 
Description of  the Outbreak. Before October 1989 
less than 2 % of nosocomial Staphylococcus 
aureus isolates were methicillin resistant in our 
hospital, and none was either aminoglycoside or
quinolone resistant. In November 1989 an 
MRSA-colonized patient, transferred directly 
from the ICU of another medical center, ap- 
parently was the index case preceding an out- 
break of MRSA infections. Special control meas- 
ures were established promptly, but the microor- 
ganisms pread extensively through the ICUs and 
some surgical wards during 1990. During the 
study period 98 health care workers had MRSA 
nasal colonization, and seven swab cultures of 
several environmental surfaces in ICUs were 
positive for MRSA. An outbreak of five cases of 
postsurgical MRSA mediastinitis was controlled 
after the identification and treatment of a nasal 
carrier belonging to a cardiac surgical team. 
Colonized patients, nasal carriage among health 
care workers, and environmental contamination 
in some ICUs were the most important factors in 
the maintenance ofthe outbreak. 
The incidence of new cases ubsided uring 1992, 
and at present the outbreak has been partially 
controlled. Nevertheless, MRSA has become n- 
demic in two of our ICUs, with a current inci- 
dence of around ten cases per month, most of 
them being mucocutaneous colonization. 
The antibiotic susceptibility patterns of the 
MRSA strains indicated resistance to methicillin, 
aminoglycosides, erythromycin, rifampin, ci- 
profloxacin and imipenem, and susceptibility to 
chloramphenicol, trimethoprim/sulfamethoxa- 
zole, vancomycin, teicoplanin, fosfomycin, mupi- 
rocin and fusidic acid. Phage typing was per- 
formed in 135 isolates. According to the Inter- 
national Phages Set, 25 isolates of MRSA 
belonged to phage Group III, two isolates to 
phage Group I, and eight isolates were lysed with 
phages of phage Groups I and III. One hundred 
isolates were nontypeable. Plasmid pattern pro- 
files studied in 40 isolates howed asingle plasmid 
(2), suggesting a unique epidemic strain as the 
Table 1: Clinical and epidemiological characteristics of 309 patients with MRSA. 
Mean age in years (± SD) 
Male/female ratio 
Mean days of hospitalization prior to 
MRSA acquisition (± SD) 
No. (%) with MRSA colonization/infection 
No. (%) with underlying disease, McCabe 
Group 1/2-3 
No. (%) with previous urgery 
Acquisition area 
No. (%) in ICUs 
No. (%) in surgical wards 
No. (%) in medical wards 
No. (%) with prior antibiotic therapy 
Beta-lactams 
Aminoglycosides 
Quinolones 
Vancomycin 
No. (%) of sites of colonization (103 patients) 
Nasal 
Mucous membranes 
Cutaneous sites 
No. (%) of sites of infection (206 patients) 
Surgical wound 
Respiratory tract 
Skin and soft tissues 
Intravascular catheter 
Bacteremia 
No, (%) of deaths attributable toMRSA 
Among infected patients 
Overall mortality 
53(±18.9) 
225(72%)184(28%) 
29.3(±28.6) 
103(30)~06(60) 
248(80.2)/61 ( 9.8) 
209(67.6) 
144 (46.6) 
143 (46,3) 
22 (7.1) 
212 (68,6) 
121 (39.1) 
45 (14.5) 
67(21.6) 
19 (6.1) 
68(66) 
36 (35) 
26(25) 
76 (36.8) 
60 (29.1) 
31 (15) 
28(13.6) 
63 (30.5) 
22/206 (10.6) 
91/309 (29.5) 
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agent responsible for the outbreak, similar to 
those strains found in other university hospitals in 
the Barcelona rea. 
Characteristics ofMRSA Colonized and Infected 
Patients. From January 1990 to December 1991, 
309 patients were identified as being colonized 
(n = 103; 33 %) or infected (n = 206; 67 %) by 
MRSA. Table 1 describes the most outstanding 
clinical and epidemiological features of these 
patients, including common sites of MRSA 
colonization and infection. Nasal mucosa was the 
most frequent site of colonization (66 %), fol- 
lowed by mucous membranes and other cu- 
taneous ites. 
Among 206 patients infected by MRSA, 67 epi- 
SOdes of MRSA bacteremia were detected in 63 
patients (30.5 %). Primary bacteremia, detected 
in 48 cases, was the most important source among 
the 67 cases of nosocomial MRSA bacteremia. 
Bacteremia nd other serious infections were 
treated with vancomycin, 500 mg i.v. every 6 h. 
Less severe infections such as superficial in- 
cisional wound infection or tracheobronchitis 
were treated with oral cotrimoxazole. Colonized 
patients, except those with nasotracheal tubes, 
tracheostomies and large decubitus ulcers, were 
treated with nasal soft paraffin mupirocin. Mor- 
tality attributable to MRSA among infected 
patients was 10.6 %. Overall mortality among the 
entire MRSA patient group was 29.5 %. 
Comparison between MRSA and MSSA Bac- 
terernia. During the two-year study period, 181 
episodes of nosocomial staphylococcal bacte- 
remia were studied prospectively. Two or more 
positive blood cultures were obtained in 116 epi- 
sodes (64 %). Sixty-seven episodes (37 %) were 
caused by MRSA and 114 (63 %) by MSSA. Since 
the introduction of MRSA, a clear upward trend 
in monthly rates of nosocomial staphylococcal 
bacteremia has been observed (Chi-square for 
trends, p < 0.01) (Figure 1). 
A comparison of the two types of bacteremia 
(Table 2) revealed that MRSA bacteremic 
patients differed significantly from the MSSA 
group in sex, underlying disease, severity of clini- 
cal status, length of hospital stay, prior exposure 
Table 2: Comparison of epidemiological and clinical features of MRSA versus MSSA episodes of 
bacteremia. 
Type of bacteremia 
Characteristic p value 
MRSA MSSA 
(n = 67) (n = 114) 
Mean age in years (± SD) 49 (± 20.6) 52.1 (± 19.8) NS 
Sex (male/female) 53/14 72/42 0.02 
No. (%) with underlying disease 
McCabe (Group 1) 51 (75) 59 (51.8) < 0.01 
Apache II (score > 15) 49 (73) 43 (37.7) < 0.01 
Mean days of prior hospital stay (±SD) 27.3 (± 25.1) 13.7 (± t8.3) < 0.01 
No. (%) with previous surgery 41 (61.1) 31 (27.1) < 0.01 
No. (%) with previous antibiotics 46 (68..6) 25 (21.9) < 0.01 
Beta-lactams 20 18 0.03 
Aminoglycosides 11 6 0.02 
Ciprofloxacin 15 2 < 0.01 
No. (%) with previous ICU setting 36 (53.7) 31 (27.2) < 0.01 
No. (%) with devices in place 
Intravascular catheter 60 (89.6) 103 (90.3) NS 
Parenteral nutrition 30 (44.7) 17 (14.9) < 0.01 
Endotracheal tube 27 (40.3) 27 (23.6) 0.01 
No. (%) with tracheostomy 24 (35.8) 7 (6.1) < 0.01 
No. (%) with following source of infection: 
Pneumonia 3 10 NS 
Mediastinitis 5 0 0.01 
Endocarditis 2 4 NS 
Miscellaneous 9 15 NS 
No. (%) with primary bacteremia 48 (71.6) 85 (74.6) NS 
Catheter-related 42 71 
Unknown source 6 14 
No. (%) of deaths 17 (38.2) 25 (30.7) NS 
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Table 3: Univariate analysis of risk factors for MRSA 
bacteremia in 309 colonized or infected patients. 
Significant variable No. (%) Odds p value 
ratio 
Prior ICU setting 38 (61) 1.6 0.06 
Tracheostomy 18 (29) 1.8 0.06 
Parenteral nutrition 26 (42) 1.9 0.01 
Intravascular catheter 53 (85) 3 < 0.01 
as the dependent variable selected only in- 
travascular catheterization (OR 2.78; (2195 %, 1.1 
to 6.6) as an independent risk factor for develop- 
ment of MRSA bacteremia. Variables included in 
the analysis were prior ICU setting, administra- 
tion of total parenteral nutrition, presence of tra- 
cheostomy and intravascular catheterization. 
to surgery, prior antibiotic therapy, prior ICU set- 
ting, administration of total parenteral nutrition, 
mechanical ventilation and tracheostomy. A
more detailed analysis of previous antibiotic ther- 
apy showed notable differences between the ad- 
ministration of beta-lactams, aminoglycosides 
and quinolones, and other antibiotics. However, 
there were no significant differences in age, 
sources of infection (except mediastinitis), in- 
travascular devices in place, and outcome be- 
tween the two groups. 
Risk Factors for MRSA Bacteremia. The univar- 
late analysis of risk factors for development of 
bacteremia (Table 3) among 309 patients with 
MRSA infection or colonization selected prior 
ICU setting, presence of tracheostomy, prior or 
current administration of total parenteral nutri- 
tion, and intravascular catheterization asstatisti- 
cally significant factors. Non-significant variables 
were age, sex, underlying disease, prior antibiotic 
therapy, intubation, urinary catheter, decubitus 
ulcers and source of infection. Unconditional lo- 
gistic regression analysis using MRSA bacteremia 
Discussion 
The major epidemiological features of our out- 
break did not differ significantly from those of 
other outbreaks (9-11). The outbreak was fo- 
cused in the ICUs, with sporadic lusters occur- 
ring in the surgical wards. In only a few cases did 
MRSA acquisition occur in the operating room, 
linked with the detection of nasal carriers among 
the surgical team. Besides colonized patients and 
health care workers, the inanimate hospital en- 
vironment appeared to be, in our experience, an 
important hospital reservoir of MRSA, as de- 
scribed previously (9,12, 13). It is noteworthy that 
in one of our ICUs, cultures of gloves worn for 
purposes of universal precautions after en- 
vironmental contact and before any contact with 
patients were positive for MRSA. However, re- 
garding the experience of other authors, the cur- 
rent relevance of environmental contamination 
may be considered controversial. 
A long interval from hospital admission to 
MRSA acquisition was characteristic, with a 
mean of 29.4 days. Prior administration of antibi- 
otic therapy was also very frequent. The role of 
"5 
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Figure 1: Monthly rates of nosocomial staphylococcal bactercmia. 
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antibiotics in the selection of resistant strains and 
in Cross-colonization appears to be relevant, but 
mechanisms have not yet been well established. 
Anterior nares and the respiratory t act in in- 
tubated patients were the most frequent sites of 
Colonization. It should be noted that nasogastric 
tubes did not permit the use of mupirocin in these 
cases (14). The clinical spectrum and sites of our 
patients' infections were in accordance with their 
Underlying diseases and clinical characteristics. 
An observation of major concern was the high in- 
cidence of patients with MRSA bacteremia. In 
OUr opinion the 30 % incidence of bacteremia ob- 
served among the entire MRSA infected popula- 
tion, similar to that reported by Peacock et al. 
(15), is higher than that among hospitalized 
Patients harboring MSSA or gram-negative 
bacilli. Nevertheless, this hypothesis  difficult o 
assess due to the lack of knowledge of the entire 
population at risk infected with MSSA or gram- 
negative bacilli. 
In contrast to some previous reports (9, 16), the 
data from our surveillance program of all blood- 
Stream infections clearly showed that MRSA iso- 
lates did not simply replace MSSA, but rather 
emerged as a distinct microorganism, increasing 
the total number of cases of staphylococcal 
bacteremia. This observation, of marked epi- 
demiological interest, has been made by Boyce et 
al. and Wenzel et al. in both bacteremic and non- 
bacteremic patients (17, 18). 
The comparison between patients with nosocom- 
ial bacteremia due to MRSA and patients with 
nosocomial bacteremia due to MSSA revealed 
that both groups had important epidemiological 
differences, but they did not differ in clinical fea- 
tures and outcome (19-21). Epidemiological fac- 
tors differentiating MRSA and MSSA bacte- 
remic patients were similar to those described as 
risk factors for acquiring MRSA colonization or 
infection among the hospital population (22, 23). 
A large number of episodes of staphylococcal 
bacteremia were defined as primary bacteremia 
in both groups (MRSA 71.6 % and MSSA 74.6 %), 
and the majority of them were catheter-related, as 
~as previously been reported by others (19, 20, 22, 
24). It remains uncertain whether MRSA differs 
from MSSA in its intrinsic ability to cause cathe- 
ter-related infections. Nevertheless, taking into 
aCCount that the number of patients colonized by 
MSSA should be greater than those colonized by 
MRSA, it may be possible that MRSA strains 
°~Sess a greater capacity to progress to infection 
In a colonized state. Again, this impression is
difficult to assess, because we do not know the 
number of MSSA colonized patients in theentire 
hospital. 
A major difference between susceptible and re- 
sistant strains was the previous administration f
antibiotics. Besides the beta-lactams and amino- 
glycosides, whose role has been previously em- 
phasized in the literature (25), it is important to 
point out the potential role of quinolones as a risk 
factor for selecting MRSA strains, since these an- 
tibiotics are being widely used in critical care 
units. 
Risk factors for the development of MRSA 
bacteremia among colonized or infected patients 
have not been established inprevious reports. Al- 
though the univariate analysis identified several 
variables associated with the development of 
MRSA bacteremia in our series of patients, the 
only variable selected by the logistic regression 
model as an independent risk factor was in- 
travascular catheterization. This data suggests 
that colonized patients with one or more in- 
travascular catheters in place are at high risk of 
developing bacteremia. This risk is perhaps 
higher than that of those colonized by MSSA or 
by other nosocomial pathogens. It i  possible that 
MRSA strains possess a unique ability to adhere 
to intravascular devices and other prosthetic 
materials, but this hypothesis should be proven in 
prospective studies. 
Recent data show that MRSA strains are at least 
equally as pathogenic as susceptible strains (26) 
and might be even more virulent (27), although 
more studies are needed to confirm this finding. 
Nevertheless, the relationship between virulence, 
spread and adherence is difficult o elucidate, and 
the factors that influence colonization and a her- 
ence, as well as the role of extracellular toxins and 
enzymes, hould be further clarified (28). In con- 
clusion, the main risk factors for nosocomial 
MRSA bacteremia identified in our study are 
similar to those described for MRSA colonization 
elsewhere. Recent antibiotic therapy, including 
treatment with the new quinolones, eems to play 
a major role. Among patients colonized or infec- 
ted by MRSA, those with intravascular devices are 
at very high risk of developing MRSA bacteremia. 
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